{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:40:25Z","timestamp":1793619625216,"version":"4.5.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Justus-Liebig-Universit\u00e4t Gie\u00dfen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Progressive supranuclear palsy (PSP) is mainly a sporadic disease. It has a multifactorial etiology and an interaction between environmental and genetic factors causes disease. While elucidation of environmental risks for PSP is still in its infancy, much has been learned about the genetic etiological component of PSP during the past few years. This article reviews genes that convey risk for PSP. All genes have been identified in association studies. Only those genes with the standard threshold for genome-wide significance of\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20095E-8 are covered. These genes include\n                    <jats:italic>MAPT, KANSL1, PLEKHM1, STX6, MOBP, EIF2AK3, SLC01 A2, DUSP10, APOE, RUNX2, TRIM11, NFASC\/CNTN2<\/jats:italic>\n                    and\n                    <jats:italic>LRRK2.<\/jats:italic>\n                    The physiologic function of these genes is described and their potential role in the etiology of PSP is discussed.\n                  <\/jats:p>","DOI":"10.1007\/s00401-025-02898-z","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T08:30:25Z","timestamp":1749025825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Multifactorial etiology of progressive supranuclear palsy (PSP): the genetic component"],"prefix":"10.1007","volume":"149","author":[{"given":"Ulrich","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"H\u00f6glinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"2898_CR1","unstructured":"Agarwal S, Gilbert R (2023) Progressive Supranuclear Palsy. [Updated 2023 Mar 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526098\/"},{"key":"2898_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar5683","author":"DR Alessi","year":"2018","unstructured":"Alessi DR, Sammler E (2018) LRRK2 kinase in Parkinson\u2019s disease. Science. https:\/\/doi.org\/10.1126\/science.aar5683","journal-title":"Science"},{"key":"2898_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1576-7","author":"M Allen","year":"2016","unstructured":"Allen M, Burgess JD, Ballard T, Serie D, Wang X, Younkin CS et al (2016) Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci. Acta Neuropath. https:\/\/doi.org\/10.1007\/s00401-016-1576-7","journal-title":"Acta Neuropath"},{"key":"2898_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00893","author":"P Alster","year":"2020","unstructured":"Alster P, Madetko N, Koziorowski D, Friedman A (2020) Microglial activation and inflammation as a factor in the pathogenesis of Progressive Supranuclear Palsy (PSP). Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.00893","journal-title":"Front Neurosci"},{"key":"2898_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1158-6_6","author":"A Amlie-Wolf","year":"2021","unstructured":"Amlie-Wolf A, Kuksa PP, Lee CY, Mlynarski E, Leung YY, Wang LS (2021) Using INFERNO to infer the molecular mechanisms underlying noncoding genetic associations. Methods Mol Biol. https:\/\/doi.org\/10.1007\/978-1-0716-1158-6_6","journal-title":"Methods Mol Biol"},{"key":"2898_CR6","doi-asserted-by":"publisher","DOI":"10.2478\/s13380-011-0021-6","author":"F Anaya","year":"2011","unstructured":"Anaya F, Lees A, de Silva R (2011) Tau gene promoter rs242557 and allele-specific protein binding. Trans Neuros. https:\/\/doi.org\/10.2478\/s13380-011-0021-6","journal-title":"Trans Neuros"},{"key":"2898_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2004.08.010","author":"A Andreadis","year":"2005","unstructured":"Andreadis A (2005) Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim Biophys Acta. https:\/\/doi.org\/10.1016\/j.bbadis.2004.08.010","journal-title":"Biochim Biophys Acta"},{"key":"2898_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105962","author":"N Badihian","year":"2024","unstructured":"Badihian N, Ali F, Botha H, Savica R, Machulda MM, Clark HM et al (2024) The MAPT p.E342K and p.R406W mutations are associated with progressive supranuclear palsy with atypical features. Parkinsonism Rel Disor. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105962","journal-title":"Parkinsonism Rel Disor"},{"key":"2898_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/8.4.711","author":"M Baker","year":"1999","unstructured":"Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J et al (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/8.4.711","journal-title":"Hum Mol Genet"},{"key":"2898_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00204","author":"P Barbier","year":"2019","unstructured":"Barbier P, Zejneli O, Martinho M, Lasorsa A, Belle V, Smet-Nocca C et al (2019) Role of Tau as a microtubule-associated protein: structural and functional aspects. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2019.00204","journal-title":"Front Aging Neurosci"},{"key":"2898_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107614","author":"A Beilina","year":"2020","unstructured":"Beilina A, Bone-Ponce L, Kumaran R et al (2020) The Parkinson\u00b4s disease protein LRRK2 interacts with the GARP complex to promote retrograde transport to the trans-Golgi Network. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2020.107614","journal-title":"Cell Rep"},{"key":"2898_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00291","author":"C Boeckx","year":"2015","unstructured":"Boeckx C, Ben\u00edtez-Burraco A (2015) Osteogenesis and neurogenesis: a robust link also for language evolution. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2015.00291","journal-title":"Front Cell Neurosci"},{"key":"2898_CR13","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201606664","author":"J Bruch","year":"2017","unstructured":"Bruch J, Xu H, R\u00f6sler TW, De Andrade A, Kuhn P-H, Lichtenthaler SF et al (2017) PERK activation mitigates tau pathology in\u00a0vitro and in\u00a0vivo. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.201606664","journal-title":"EMBO Mol Med"},{"key":"2898_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2007.04.006","author":"TM Caffrey","year":"2007","unstructured":"Caffrey TM, Wade-Martins R (2007) Functional MAPT haplotypes: bridging the gap between genotype and neuropathology. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2007.04.006","journal-title":"Neurobiol Dis"},{"key":"2898_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0270-8","author":"JA Chen","year":"2018","unstructured":"Chen JA, Chen Z, Won H et al (2018) Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-018-0270-8","journal-title":"Mol Neurodegener"},{"key":"2898_CR16","doi-asserted-by":"publisher","DOI":"10.2174\/1389450043345236","author":"F Chen","year":"2004","unstructured":"Chen F, David D, Ferrari A, Gotz J (2004) Posttranslational modifications of tau-role in human tauopathies and modeling in transgenic animals. Curr Drug Targets. https:\/\/doi.org\/10.2174\/1389450043345236","journal-title":"Curr Drug Targets"},{"key":"2898_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00476-x","author":"DC Chung","year":"2021","unstructured":"Chung DC, Roemer S, Petrucelli L, Dickson DW (2021) Cellular and pathological heterogeneity of primary tauopathies. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-021-00476-x","journal-title":"Mol Neurodegener"},{"key":"2898_CR18","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-051116-05235884","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-05235884","journal-title":"Annu Rev Immunol"},{"key":"2898_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157924","author":"KG Coupland","year":"2016","unstructured":"Coupland KG, Kim WS, Halliday GM, Hallupp M, Dobson-Stone C, Kwok JBJ (2016) Role of the long non-coding RNA MAPT-AS1 in regulation of microtubule associated protein Tau (MAPT) expression in Parkinson\u00b4s disease. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0157924","journal-title":"PLoS ONE"},{"key":"2898_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e32833be924","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA (2010) Neuropathology of variants of progressive supranuclear palsy. Curr Opinion Neurol. https:\/\/doi.org\/10.1097\/WCO.0b013e32833be924","journal-title":"Curr Opinion Neurol"},{"key":"2898_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400180","author":"D Di Lorenzo","year":"2024","unstructured":"Di Lorenzo D (2024) Tau protein and tauopathies: exploring tau protein\u2013protein and microtubule interactions, cross-interactions and therapeutic strategies. Chem Med Chem. https:\/\/doi.org\/10.1002\/cmdc.202400180","journal-title":"Chem Med Chem"},{"key":"2898_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz248","author":"S Efthymiou","year":"2019","unstructured":"Efthymiou S, Salpietro V, Malintan N, Poncelet M, Kriouile Y et al (2019) Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination. Brain. https:\/\/doi.org\/10.1093\/brain\/awz248","journal-title":"Brain"},{"key":"2898_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00058","author":"M Elkouris","year":"2019","unstructured":"Elkouris M, Kouroupi G, Vourvoukelis A (2019) Long non-coding RNAs Associated with Neurodegeneration-linked genes are reduced in Parkinson\u2019s Disease patients. Front Cell Neurosci, Sec Cell Neuropathol. https:\/\/doi.org\/10.3389\/fncel.2019.00058","journal-title":"Front Cell Neurosci, Sec Cell Neuropathol"},{"key":"2898_CR24","doi-asserted-by":"publisher","DOI":"10.1101\/2020.08.11.246363","author":"LD Evans","year":"2020","unstructured":"Evans LD, Strano A, Campbell A et al (2020) Whole genome CRISPR screens identify LRRK2-regulated endocytosis as a major mechanism for extracellular tau uptake by human neurons. BioRxiv. https:\/\/doi.org\/10.1101\/2020.08.11.246363","journal-title":"BioRxiv"},{"key":"2898_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2012.03.003","author":"GD Fairn","year":"2012","unstructured":"Fairn GD, Grinstein S (2012) How nascent phagosomes mature to become phagolysosomes. Trends Immunol. https:\/\/doi.org\/10.1016\/j.it.2012.03.003","journal-title":"Trends Immunol"},{"key":"2898_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52025-x","author":"K Farrell","year":"2024","unstructured":"Farrell K, Humphrey J, Chang T, Zhao Y, Leung YY et al (2024) Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-024-52025-x","journal-title":"Nat Commun"},{"key":"2898_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2014.01.010","author":"R Ferrari","year":"2015","unstructured":"Ferrari R, Ryten M, Simone R, Trabzuni D, Nicolaou N, Hondhamuni G et al (2015) Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy. Neurobiol Aging. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.01.010","journal-title":"Neurobiol Aging"},{"key":"2898_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2019.03.027","author":"RS Fine","year":"2019","unstructured":"Fine RS, Pers TH, Amariuta T, Raychaudhuri S, Hirschhorn JN (2019) Benchmarker: An unbiased, association-data-driven strategy to evaluate gene prioritization algorithms. Am J Hum Genet. https:\/\/doi.org\/10.1016\/j.ajhg.2019.03.027","journal-title":"Am J Hum Genet"},{"key":"2898_CR29","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2022.34","author":"SL Forrest","year":"2023","unstructured":"Forrest SL, Kovacs GG (2023) Current concepts of mixed pathologies in neurodegenerative diseases. Can J Neurol Sci. https:\/\/doi.org\/10.1017\/cjn.2022.34","journal-title":"Can J Neurol Sci"},{"key":"2898_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-023-02604-x","author":"SL Forrest","year":"2023","unstructured":"Forrest SL, Lee S, Nassir N, Martinez-Valbuena I, Sackmann V, Li J et al (2023) Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in progressive supranuclear palsy. Acta Neuropath. https:\/\/doi.org\/10.1007\/s00401-023-02604-x","journal-title":"Acta Neuropath"},{"key":"2898_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01588-0","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y et al (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Sig Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-023-01588-0","journal-title":"Sig Transduct Target Ther"},{"key":"2898_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.779385","author":"Y Gao","year":"2021","unstructured":"Gao Y, Kong L, Liu S, Liu K, Zhu J (2021) Impact of neurofascin on chronic inflammatory demyelinating polyneuropathy via changing the node of Ranvier function: a review. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2021.779385","journal-title":"Front Mol Neurosci"},{"key":"2898_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2014.00032","author":"BK Gilsbach","year":"2014","unstructured":"Gilsbach BK, Kortholt A (2014) A structural biology of the LRRK2 GTPase and kinase domainsz implications for regulation. Front Mol Neurosci Sec. https:\/\/doi.org\/10.3389\/fnmol.2014.00032","journal-title":"Front Mol Neurosci Sec"},{"key":"2898_CR34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.11.4051","author":"M Goedert","year":"1988","unstructured":"Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.85.11.4051","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2898_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-017-1707-9","author":"T Guo","year":"2017","unstructured":"Guo T, Noble W, Hanger DP (2017) Roles of tau protein in health and disease. Acta Neuropath. https:\/\/doi.org\/10.1007\/s00401-017-1707-9","journal-title":"Acta Neuropath"},{"key":"2898_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2012.10.009","author":"B Hagenbuch","year":"2013","unstructured":"Hagenbuch B, Stieger B (2013) The SLCO (former SLC21) superfamily of transporters. Mol Aspects Med. https:\/\/doi.org\/10.1016\/j.mam.2012.10.009","journal-title":"Mol Aspects Med"},{"key":"2898_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.23614","author":"M Hamm","year":"2015","unstructured":"Hamm M, Bailey R, Shaw G, Yen SH, Lewis J, Giasson BI (2015) Physiologically relevant factors influence tau phosphorylation by leucine-rich repeat kinase 2. J Neurosci Res. https:\/\/doi.org\/10.1002\/jnr.23614","journal-title":"J Neurosci Res"},{"key":"2898_CR38","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.0250","author":"MG Heckman","year":"2019","unstructured":"Heckman MG, Brennan RR, Labb\u00e9 C, Soto AI, Koga S, DeTure MA et al (2019) Association of MAPT subhaplotypes with risk of progressive supranuclear palsy and severity of tau pathology. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2019.0250","journal-title":"JAMA Neurol"},{"key":"2898_CR39","doi-asserted-by":"publisher","DOI":"10.1101\/2024.06.21.24309279","author":"PG-G H\u00e9ctor","year":"2024","unstructured":"H\u00e9ctor PG-G, Lara HR, Compta Y et al (2024) A novel susceptibility locus in NFASC highlights oligodendrocytes and myelination in Progressive Supranuclear Palsy pathology. med RXIV preprint. https:\/\/doi.org\/10.1101\/2024.06.21.24309279","journal-title":"med RXIV preprint"},{"key":"2898_CR40","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20210383","author":"S Herbst","year":"2021","unstructured":"Herbst S, Lewis PA (2021) From structure to etiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson\u2019s disease. Biochem J. https:\/\/doi.org\/10.1042\/BCJ20210383","journal-title":"Biochem J"},{"key":"2898_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3270","author":"C Hetz","year":"2012","unstructured":"Hetz C (2012) The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. https:\/\/doi.org\/10.1038\/nrm3270","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2898_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26987","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria: MDS clinical diagnostic criteria for PSP. Mov Disor. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disor"},{"key":"2898_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ng.859","author":"GU H\u00f6glinger","year":"2011","unstructured":"H\u00f6glinger GU, Melhem NM, Dickson DW et al (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet. https:\/\/doi.org\/10.1038\/ng.859","journal-title":"Nat Genet"},{"key":"2898_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26820","author":"V Huin","year":"2016","unstructured":"Huin V, Deramecourt V, Caparros-Lefebvre D et al (2016) The MAPT gene is differentially methylated in the progressive supranuclear palsy brain. Mov Disorders. https:\/\/doi.org\/10.1002\/mds.26820","journal-title":"Mov Disorders"},{"key":"2898_CR45","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.387977","author":"R Hu","year":"2024","unstructured":"Hu R, Dun X, Singh L, Banton MC (2024) Runx2 regulates peripheral nerve regeneration to promote Schwann cell migration and re-myelination. Neural Regen Res. https:\/\/doi.org\/10.4103\/1673-5374.387977","journal-title":"Neural Regen Res"},{"key":"2898_CR46","doi-asserted-by":"publisher","DOI":"10.14802\/jmd.15033","author":"SY Im","year":"2025","unstructured":"Im SY, Kim YE, Kim YJ (2025) Genetics of progressive supranuclear palsy. J Mov Disor. https:\/\/doi.org\/10.14802\/jmd.15033","journal-title":"J Mov Disor"},{"key":"2898_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/60.6.647","author":"K Ishizawa","year":"2001","unstructured":"Ishizawa K, Dickson DW (2001) Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J Neuropathol Exp Neurol. https:\/\/doi.org\/10.1093\/jnen\/60.6.647","journal-title":"J Neuropathol Exp Neurol"},{"key":"2898_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnsyn.2022.826098","author":"D Ivanova","year":"2022","unstructured":"Ivanova D, Cousin MA (2022) Synaptic vesicle recycling and the endolysosomal system: a reappraisal of form and function. Front Synap Neurosci. https:\/\/doi.org\/10.3389\/fnsyn.2022.826098","journal-title":"Front Synap Neurosci"},{"key":"2898_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30394-X","author":"E Jabbari","year":"2021","unstructured":"Jabbari E, Koga S, Valentino RR et al (2021) Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(20)30394-X","journal-title":"Lancet Neurol"},{"key":"2898_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25308","author":"E Jabbari","year":"2018","unstructured":"Jabbari E, Woodside J, Tan MMX et al (2018) Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.25308","journal-title":"Ann Neurol"},{"key":"2898_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-023-00668-x","author":"R Jahn","year":"2024","unstructured":"Jahn R, Cafiso DC, Tamm LK (2024) Mechanisms of SNARE proteins in membrane fusion. Nat Rev Mol Cell Biol. https:\/\/doi.org\/10.1038\/s41580-023-00668-x","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2898_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12579","author":"F Kawakami","year":"2014","unstructured":"Kawakami F, Shimada N, Ohta E, Kagiya G, Kawashima R, Maekawa T et al (2014) Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3\u03b2. FEBS J. https:\/\/doi.org\/10.1111\/febs.12579","journal-title":"FEBS J"},{"key":"2898_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2012.01.012","author":"M Kriebel","year":"2012","unstructured":"Kriebel M, Wuchter J, Trinks S, Volkmer H (2012) Neurofascin: a switch between neuronal plasticity and stability. Int J Bioch Cell Biol. https:\/\/doi.org\/10.1016\/j.biocel.2012.01.012","journal-title":"Int J Bioch Cell Biol"},{"key":"2898_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.804385","author":"A Krzosek","year":"2022","unstructured":"Krzosek A, Madetko N, Migda B, Migda M, Jagu\u015b D, Alster P (2022) Differential diagnosis of rare subtypes of Progressive Supranuclear Palsy (PSP) and PSP-like syndromes -infrequent manifestations of the most common form of atypical parkinsonism. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2022.804385","journal-title":"Front Aging Neurosci"},{"key":"2898_CR55","doi-asserted-by":"publisher","DOI":"10.1124\/mol.116.105544","author":"HH Lee","year":"2016","unstructured":"Lee HH, Leake BF, Kim RB, Ho RH (2016) Contribution of organic anion-transporting polypeptides 1A\/1B to doxorubicin uptake and clearance. Mol Pharma. https:\/\/doi.org\/10.1124\/mol.116.105544","journal-title":"Mol Pharma"},{"key":"2898_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1372507","author":"H Li","year":"2024","unstructured":"Li H, Li Q, Weng Q, Cui R, Yen TC, Li Y (2024) A novel MAPT variant (E342K) as a cause of familial progressive supranuclear palsy. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2024.1372507","journal-title":"Front Neurol"},{"key":"2898_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28613-0","author":"T Li","year":"2022","unstructured":"Li T, Lu D, Yao C et al (2022) Kansl1 haploinsufficiency impairs autophagosome-lysosome fusion and links autophagic dysfunction with Koolen-de Vries syndrome. Nature Comm. https:\/\/doi.org\/10.1038\/s41467-022-28613-0","journal-title":"Nature Comm"},{"key":"2898_CR58","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2021.1936777","author":"K Linda","year":"2021","unstructured":"Linda K, Lewerissa EI, Verboven AHA et al (2021) Imbalanced autophagy causes synaptic deficits in a human model for neurodevelopmental disorders. Autophagy. https:\/\/doi.org\/10.1080\/15548627.2021.1936777","journal-title":"Autophagy"},{"key":"2898_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26512","author":"I Litvan","year":"2016","unstructured":"Litvan I, Lees PS, Cunningham CR, Rai SN, Cambon AC, Standaert DG et al (2016) Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study. Mov Disor. https:\/\/doi.org\/10.1002\/mds.26512","journal-title":"Mov Disor"},{"key":"2898_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11791-2","author":"S Lyons","year":"2023","unstructured":"Lyons S, Trepel D, Lynch T, Walsh R, O\u2019dowd S (2023) The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis. J Neurol. https:\/\/doi.org\/10.1007\/s00415-023-11791-2","journal-title":"J Neurol"},{"key":"2898_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325549","author":"M Malpetti","year":"2021","unstructured":"Malpetti M, Passamonti L, Jones PS et al (2021) Neuroinflammation predicts disease progression in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2020-325549","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2898_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2012.06.003","author":"L Martin","year":"2013","unstructured":"Martin L, Latypova X, Wilson CM et al (2013) Tau protein kinases: Involvement in Alzheimer\u2019s disease. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2012.06.003","journal-title":"Ageing Res Rev"},{"key":"2898_CR63","doi-asserted-by":"publisher","DOI":"10.1080\/19336918.2016.1269998","author":"T Masuda","year":"2017","unstructured":"Masuda T (2017) Contactin-2\/TAG-1, active on the front line for three decades. Cell Adher Migr. https:\/\/doi.org\/10.1080\/19336918.2016.1269998","journal-title":"Cell Adher Migr"},{"key":"2898_CR64","doi-asserted-by":"publisher","DOI":"10.1097\/01.jnen.0000235121.98052.54","author":"J Miklossy","year":"2006","unstructured":"Miklossy J, Arai T, Jian-Ping Guo J-P et al (2006) LRRK2 expression in normal and pathologic human brain and in human cell lines. J Neuropathol Exp Neurol. https:\/\/doi.org\/10.1097\/01.jnen.0000235121.98052.54","journal-title":"J Neuropathol Exp Neurol"},{"key":"2898_CR65","doi-asserted-by":"publisher","DOI":"10.1159\/000095110","author":"P Montague","year":"2006","unstructured":"Montague P, McCallion AS, Davies RW, Griffiths IR (2006) Myelin-associated oligodendrocytic basic protein: a family of abundant CNS myelin proteins in search of a function. Dev Neurosc. https:\/\/doi.org\/10.1159\/000095110","journal-title":"Dev Neurosc"},{"key":"2898_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.04.009","author":"M Morris","year":"2011","unstructured":"Morris M, Maeda S, Vossel K, Mucke L (2011) The many faces of tau. Neuron. https:\/\/doi.org\/10.1016\/j.neuron.2011.04.009","journal-title":"Neuron"},{"key":"2898_CR67","unstructured":"NCBI: KANSL1 KAT8 regulatory NSL complex subunit 1 (Homo sapiens) Gene ID: 284058, updated on 8-Mar-2025"},{"key":"2898_CR68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.163350810","author":"D Panda","year":"2003","unstructured":"Panda D, Samuel JC, Massie M, Feinstein SC, Wilson L (2003) Differential regulation of microtubule dynamics by three- and four-repeat tau: Implications for the onset of neurodegenerative disease. Proc Natl Acad Sci. https:\/\/doi.org\/10.1073\/pnas.163350810","journal-title":"Proc Natl Acad Sci"},{"key":"2898_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20081999","author":"R P\u00e9rez-Sen","year":"2019","unstructured":"P\u00e9rez-Sen R, Queipo MJ, Gil-Redondo JC, Ortega F, G\u00f3mez-Villafuertes R, Miras-Portugal MT et al (2019) Dual-specificity phosphatase regulation in neurons and glial cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20081999","journal-title":"Int J Mol Sci"},{"key":"2898_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2011.06.002","author":"FW Pfrieger","year":"2011","unstructured":"Pfrieger FW, Ungerer N (2011) Cholesterol metabolism in neurons and astrocytes. Prog Lipid Res. https:\/\/doi.org\/10.1016\/j.plipres.2011.06.002","journal-title":"Prog Lipid Res"},{"key":"2898_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(87)90295-5","author":"ER Pitas","year":"1987","unstructured":"Pitas ER, Boyles JK, Lee SH, Foss D, Mahley RW (1987) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. BBA Lipids and Lipid Metabol. https:\/\/doi.org\/10.1016\/0005-2760(87)90295-5","journal-title":"BBA Lipids and Lipid Metabol"},{"key":"2898_CR72","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2005.031377","author":"AM Pittman","year":"2005","unstructured":"Pittman AM, Myers AJ, Abou-Sleiman P et al (2005) Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet. https:\/\/doi.org\/10.1136\/jmg.2005.031377","journal-title":"J Med Genet"},{"key":"2898_CR73","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi361","author":"R Rademakers","year":"2005","unstructured":"Rademakers R, Melquist S, Cruts M, Theuns J, Del-Favero J, Poorkaj P et al (2005) High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddi361","journal-title":"Hum Mol Genet"},{"key":"2898_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/biology10050384","author":"A Read","year":"2021","unstructured":"Read A, Schr\u00f6der M (2021) The unfolded protein response: an overview. Biology. https:\/\/doi.org\/10.3390\/biology10050384","journal-title":"Biology"},{"key":"2898_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054317","author":"ME Reale","year":"2013","unstructured":"Reale ME, Webb IC, Wang X, Baltazar RM, Coolen LM, Lehman MN (2013) The transcription factor Runx2 is under circadian control in the suprachiasmatic nucleus and functions in the control of rhythmic behavior. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0054317","journal-title":"PLoS ONE"},{"key":"2898_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-024-01839-3","author":"HW Ressler","year":"2024","unstructured":"Ressler HW, Humphrey J, Vialle RA, Babrowicz B, Kandoi S, Raj T et al (2024) MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy. Acta Neuropath Commun. https:\/\/doi.org\/10.1186\/s40478-024-01839-3","journal-title":"Acta Neuropath Commun"},{"key":"2898_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101644","author":"TW R\u00f6sler","year":"2019","unstructured":"R\u00f6sler TW, Marvian AT, Brendel N-P, H\u00f6llerhage M, Schwarz SC et al (2019) Four repeat tauopathies. Prog Neuro. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101644","journal-title":"Prog Neuro"},{"key":"2898_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2023.12.015","author":"BB Rogers","year":"2024","unstructured":"Rogers BB, Anderson AG, Lauzon SN et al (2024) Neuronal MAPT expression is mediated by long-range interactions with cis-regulatory elements. Am J Hum Genet. https:\/\/doi.org\/10.1016\/j.ajhg.2023.12.015","journal-title":"Am J Hum Genet"},{"key":"2898_CR79","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202111077","author":"JC Roney","year":"2022","unstructured":"Roney JC, Cheng XT, Sheng ZH (2022) Neuronal endolysosomal transport and lysosomal functionality in maintaining axonostasis. J Cell Biol. https:\/\/doi.org\/10.1083\/jcb.202111077","journal-title":"J Cell Biol"},{"key":"2898_CR80","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2020-002794","author":"JB Rowe","year":"2021","unstructured":"Rowe JB, Holland N, Rittman T (2021) Progressive supranuclear palsy: diagnosis and management. Pract Neurol. https:\/\/doi.org\/10.1136\/practneurol-2020-002794","journal-title":"Pract Neurol"},{"key":"2898_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0267-3","author":"MY Sanchez-Contreras","year":"2018","unstructured":"Sanchez-Contreras MY, Kouri N, Cook CN et al (2018) Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-018-0267-3","journal-title":"Mol Neurodegener"},{"key":"2898_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4000285","author":"A Sawa","year":"1997","unstructured":"Sawa A, Amano N, Yamada N et al (1997) Apolipoprotein E in progressive supranuclear palsy in Japan. Mol Psychiatry. https:\/\/doi.org\/10.1038\/sj.mp.4000285","journal-title":"Mol Psychiatry"},{"key":"2898_CR83","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199605000-00006","author":"ML Schmidt","year":"1996","unstructured":"Schmidt ML, Huang R, Martin JA, Henley J, Mawal-Dewan M, Hurtig HI et al (1996) Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer\u2019s disease PHFtau. J Neuropath Exp Neurol. https:\/\/doi.org\/10.1097\/00005072-199605000-00006","journal-title":"J Neuropath Exp Neurol"},{"key":"2898_CR84","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201847630","author":"BN Sheikh","year":"2019","unstructured":"Sheikh BN, Guhathakurta S, Akhtar A (2019) The non-specific lethal (NSL) complex at the crossroads of transcriptional control and cellular homeostasis. EMBO Rep. https:\/\/doi.org\/10.15252\/embr.201847630","journal-title":"EMBO Rep"},{"key":"2898_CR85","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.18243.PMID:39512309;PMCID:PMC11542561","author":"VV Shiryagin","year":"2024","unstructured":"Shiryagin VV, Devyatkin AA, Fateev OD et al (2024) Genomic complexity and clinical significance of the RCCX locus. PeerJ. https:\/\/doi.org\/10.7717\/peerj.18243.PMID:39512309;PMCID:PMC11542561","journal-title":"PeerJ"},{"key":"2898_CR86","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.185728","author":"A Siddiqua","year":"2010","unstructured":"Siddiqua A, Margittai M (2010) Three- and four-repeat Tau co-assemble into heterogeneous filaments: an implication for Alzheimer disease. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M110.185728","journal-title":"J Biol Chem"},{"key":"2898_CR87","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac325","author":"MPM Soutar","year":"2022","unstructured":"Soutar MPM, Melandri D, O\u2019Callaghan B et al (2022) Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson\u2019s disease at 16q11.2 and MAPT H1 loci. Brain. https:\/\/doi.org\/10.1093\/brain\/awac325","journal-title":"Brain"},{"key":"2898_CR88","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a013391","author":"A Spang","year":"2013","unstructured":"Spang A (2013) Retrograde traffic from the Golgi to the endoplasmic reticulum. Cold Spring Harb Perspective Biol. https:\/\/doi.org\/10.1101\/cshperspect.a013391","journal-title":"Cold Spring Harb Perspective Biol"},{"key":"2898_CR89","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.5.880","author":"PM Stanford","year":"2000","unstructured":"Stanford PM, Halliday GM, Brooks WS, Kwok JB, Storey CE, Creasey H et al (2000) Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. Brain. https:\/\/doi.org\/10.1093\/brain\/123.5.880","journal-title":"Brain"},{"key":"2898_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-1-31","author":"LD Stutzbach","year":"2013","unstructured":"Stutzbach LD, Xie SX, Naj AC, Albin R, Gilman S, Lee VM et al (2013) The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer\u2019s disease. Acta Neuropath Commun. https:\/\/doi.org\/10.1186\/2051-5960-1-31","journal-title":"Acta Neuropath Commun"},{"key":"2898_CR91","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E10-06-0495","author":"K Tabata","year":"2010","unstructured":"Tabata K, Matsunaga K, Sakane A, Sasaki T, Noda T et al (2010) PLEKHM1 negatively regulate the endocytic\/autophagic pathway via a novel Rab7-binding domain. Mol Biol Cell. https:\/\/doi.org\/10.1091\/mbc.E10-06-0495","journal-title":"Mol Biol Cell"},{"key":"2898_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00544-7","author":"JM Taymans","year":"2023","unstructured":"Taymans JM, Fell M, Greenamyre T et al (2023) Perspective on the current state of the LRR2 field. NPJ Parkinson\u2019s Dis. https:\/\/doi.org\/10.1038\/s41531-023-00544-7","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"2898_CR93","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000304051.01650.233","author":"JE Tobin","year":"2008","unstructured":"Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA et al (2008) Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology. https:\/\/doi.org\/10.1212\/01.wnl.0000304051.01650.233","journal-title":"Neurology"},{"key":"2898_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.041","author":"TE Tracy","year":"2022","unstructured":"Tracy TE, Madero-P\u00e9rez J, Swaney DL et al (2022) Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell. https:\/\/doi.org\/10.1016\/j.cell.2021.12.041","journal-title":"Cell"},{"key":"2898_CR95","doi-asserted-by":"publisher","DOI":"10.1111\/neup.12143","author":"B Trinczek","year":"1995","unstructured":"Trinczek B, Biernat J, Baumann K, Mandelkow EM, Mandelkow E (1995) Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules. Mol Biol Cell. https:\/\/doi.org\/10.1111\/neup.12143","journal-title":"Mol Biol Cell"},{"key":"2898_CR96","doi-asserted-by":"publisher","DOI":"10.1101\/gad.471708","author":"TC Tuoc","year":"2008","unstructured":"Tuoc TC, Stoykova A (2008) Trim11 modulates the function of neurogenic transcription factor Pax6 through ubiquitin-proteosome system. Genes Dev. https:\/\/doi.org\/10.1101\/gad.471708","journal-title":"Genes Dev"},{"key":"2898_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s43586-021-00056-9","author":"E Uffelmann","year":"2021","unstructured":"Uffelmann E, Huang QQ, Munung N et al (2021) Genome-wide association studies. Nat Rev Methods Primers. https:\/\/doi.org\/10.1038\/s43586-021-00056-9","journal-title":"Nat Rev Methods Primers"},{"key":"2898_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28010","author":"RR Valentino","year":"2020","unstructured":"Valentino RR, Koga S, Heckman MG et al (2020) Association of tripartite motif containing 11 rs564309 with tau pathology in Progressive Supranuclear Palsy. Mov Disorders. https:\/\/doi.org\/10.1002\/mds.28010","journal-title":"Mov Disorders"},{"key":"2898_CR99","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30328","author":"L Van Wesenbeeck","year":"2007","unstructured":"Van Wesenbeeck L, Odgren PR, Coxon FP et al (2007) Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI30328","journal-title":"J Clin Invest"},{"key":"2898_CR100","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.149849","author":"JS Vidal","year":"2009","unstructured":"Vidal JS, Vidailhet M, Derkinderen P, de Gaillarbois TD, Tzourio C, Alp\u00e9rovitch A (2009) Risk factors for progressive supranuclear palsy: a case-control study in France. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp.2008.149849","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2898_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-024-00747-3","author":"H Wang","year":"2024","unstructured":"Wang H, Chang TS, Dombroski BA et al (2024) Whole-Genome sequencing analysis reveals new susceptibility loci and structural variants associated with Progressive Supranuclear Palsy. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-024-00747-3","journal-title":"Mol Neurodegener"},{"key":"2898_CR102","doi-asserted-by":"publisher","DOI":"10.1002\/mds.30150","author":"H Wang","year":"2025","unstructured":"Wang H, Chang TS, Dombroski BA, et al (2025) Copy number variation and haplotype analysis of 17q21.31 reveals increased risk associated with Progressive Supranuclear Palsy and gene expression changes in neuronal cells. Mov Disorders. https:\/\/doi.org\/10.1002\/mds.30150","journal-title":"Mov Disorders"},{"key":"2898_CR103","first-page":"103","volume-title":"RUNX Proteins in development and cancer advances in experimental medicine and biology","author":"JW Wang","year":"2017","unstructured":"Wang JW, Stifani S (2017) Roles of Runx genes in nervous system development. In: Groner Y, Ito Y, Liu P, Neil J, Speck N, van Wijnen A (eds) RUNX Proteins in development and cancer advances in experimental medicine and biology. Springer, Singapore, pp 103\u2013116"},{"key":"2898_CR104","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.5","author":"MD Weingarten","year":"1975","unstructured":"Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.72.5","journal-title":"Proc Natl Acad Sci USA"},{"key":"2898_CR105","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-202302","author":"Y Wen","year":"2020","unstructured":"Wen Y, Zhou Y, Jiao B, Shen L (2020) Genetics of progressive supranuclear palsy: a review. J Parkinson\u2019s Dis. https:\/\/doi.org\/10.3233\/JPD-202302","journal-title":"J Parkinson\u2019s Dis"},{"key":"2898_CR106","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0854.2001.20903.x","author":"F Wendler","year":"2001","unstructured":"Wendler F, Tooze SA (2001) Syntaxin-6: the promiscuous behavior of a SNARE protein. Traffic. https:\/\/doi.org\/10.1034\/j.1600-0854.2001.20903.x","journal-title":"Traffic"},{"key":"2898_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.840266","author":"LJ Westacott","year":"2022","unstructured":"Westacott LJ, Wilkinson LS (2022) Complement dependent synaptic reorganisation during critical periods of brain development and risk for psychiatric disorder. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2022.840266","journal-title":"Front Neurosci"},{"key":"2898_CR108","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.73.11.4070","author":"GB Witman","year":"1976","unstructured":"Witman GB, Cleveland DW, Weingarten MD, Kirschner MW (1976) Tubulin requires tau for growth onto microtubule initiating sites. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.73.11.4070","journal-title":"Proc Natl Acad Sci USA"},{"key":"2898_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)31756-3","author":"Y Yamamoto","year":"1994","unstructured":"Yamamoto Y, Mizuno R, Nishimura T et al (1994) Cloning and expression of myelin-associated oligodendrocytic basic protein. a novel basic protein constituting the central nervous system myelin. J Biol Chem. https:\/\/doi.org\/10.1016\/S0021-9258(18)31756-3","journal-title":"J Biol Chem"},{"key":"2898_CR110","doi-asserted-by":"publisher","DOI":"10.1111\/neup.12143","author":"M Yoshida","year":"2014","unstructured":"Yoshida M (2014) Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration. Neuropathology. https:\/\/doi.org\/10.1111\/neup.12143","journal-title":"Neuropathology"},{"key":"2898_CR111","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy297","author":"SH Yuan","year":"2018","unstructured":"Yuan SH, Hiramatsu N, Liu Q et al (2018) Tauopathy-associated PERK alleles are functional hypomorphs that increase neuronal vulnerability to ER stress. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddy297","journal-title":"Hum Mol Genet"},{"key":"2898_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/baiom13040612","author":"X Zhang","year":"2023","unstructured":"Zhang X, Kortholt A (2023) LRRK2 structure-based activation mechanism and pathogenesis. Biomolecules. https:\/\/doi.org\/10.3390\/baiom13040612","journal-title":"Biomolecules"},{"key":"2898_CR113","doi-asserted-by":"publisher","DOI":"10.1126\/science.add6696","author":"Z-Y Zhang","year":"2023","unstructured":"Zhang Z-Y, Harischandra DS, Wang R et al (2023) TRIM11 protects against tauopathies and is down-regulated in Alzheimer\u2019s disease. Science. https:\/\/doi.org\/10.1126\/science.add6696","journal-title":"Science"},{"key":"2898_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06783-0","author":"N Zhao","year":"2018","unstructured":"Zhao N, Liu CC, Van Ingelgom AJ et al (2018) APOE \u03b52 is associated with increased tau pathology in primary tauopathy. Nat Comm. https:\/\/doi.org\/10.1038\/s41467-018-06783-0","journal-title":"Nat Comm"},{"key":"2898_CR115","doi-asserted-by":"publisher","DOI":"10.1159\/000381313","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Yuan J, Li Z et al (2015) Genetic polymorphisms and function of the organic anion-transporting polypeptide 1A2 and its clinical relevance in drug disposition. Pharmacology. https:\/\/doi.org\/10.1159\/000381313","journal-title":"Pharmacology"},{"key":"2898_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108418","author":"G Zhu","year":"2020","unstructured":"Zhu G, Harischandra DS, Ghaisas S, Zhang P, Prall W, Huang L et al (2020) TRIM11 prevents and reverses protein aggregation and rescues a mouse model of Parkinson\u2019s disease. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2020.108418","journal-title":"Cell Rep"},{"key":"2898_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002707","author":"F Zou","year":"2012","unstructured":"Zou F, Chai HS, Younkin CS et al (2012) Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet. https:\/\/doi.org\/10.1371\/journal.pgen.1002707","journal-title":"PLoS Genet"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02898-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-025-02898-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02898-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T08:30:29Z","timestamp":1749025829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-025-02898-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":117,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2898"],"URL":"https:\/\/doi.org\/10.1007\/s00401-025-02898-z","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"58"}}